My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 255

    1.

    Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system.

    Stoff-Khalili MA, Stoff A, Rivera AA, Banerjee NS, Everts M, Young S, Siegal GP, Richter DF, Wang M, Dall P, Mathis JM, Zhu ZB, Curiel DT.

    Breast Cancer Res. 2005;7(6):R1141-52. Epub 2005 Nov 16.PMID: 16457694 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Evaluation of tumor-specific promoter activities in melanoma.

    Lu B, Makhija SK, Nettelbeck DM, Rivera AA, Wang M, Komarova S, Zhou F, Yamamoto M, Haisma HJ, Alvarez RD, Curiel DT, Zhu ZB.

    Gene Ther. 2005 Feb;12(4):330-8.PMID: 15696177 [PubMed - indexed for MEDLINE]Related articles

    3.

    Evaluation of tissue-specific promoters in carcinomas of the cervix uteri.

    Rein DT, Breidenbach M, Nettelbeck DM, Kawakami Y, Siegal GP, Huh WK, Wang M, Hemminki A, Bauerschmitz GJ, Yamamoto M, Adachi Y, Takayama K, Dall P, Curiel DT.

    J Gene Med. 2004 Nov;6(11):1281-9.PMID: 15368588 [PubMed - indexed for MEDLINE]Related articles

    4.

    Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.

    Zhu ZB, Makhija SK, Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA 3rd, Yamamoto M, Alvarez RD, Curiel DT.

    Gene Ther. 2004 Apr;11(7):645-8. Erratum in: Gene Ther. 2006 Feb;13(4):374. Yamaoto, M [corrected to Yamamoto, M]. PMID: 15029227 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.

    Ulasov IV, Rivera AA, Sonabend AM, Rivera LB, Wang M, Zhu ZB, Lesniak MS.

    Cancer Biol Ther. 2007 May;6(5):679-85. Epub 2007 Feb 3.PMID: 17404502 [PubMed - indexed for MEDLINE]Related articles

    6.

    Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.

    Stoff-Khalili MA, Rivera AA, Stoff A, Michael Mathis J, Rocconi RP, Matthews QL, Numnum MT, Herrmann I, Dall P, Eckhoff DE, Douglas JT, Siegal GP, Zhu ZB, Curiel DT.

    Int J Cancer. 2007 Feb 15;120(4):935-41.PMID: 17131341 [PubMed - indexed for MEDLINE]Related articles

    7.

    The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.

    Barker SD, Coolidge CJ, Kanerva A, Hakkarainen T, Yamamoto M, Liu B, Rivera AA, Bhoola SM, Barnes MN, Alvarez RD, Curiel DT, Hemminki A.

    J Gene Med. 2003 Apr;5(4):300-10.PMID: 12692864 [PubMed - indexed for MEDLINE]Related articles

    8.

    Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system.

    Stoff-Khalili MA, Stoff A, Rivera AA, Mathis JM, Everts M, Wang M, Kawakami Y, Waehler R, Mathews QL, Yamamoto M, Rocconi RP, Siegal GP, Richter DF, Dall P, Zhu ZB, Curiel DT.

    Cancer Biol Ther. 2005 Nov;4(11):1203-10. Epub 2005 Nov 8.PMID: 16177567 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter.

    Haviv YS, van Houdt WJ, Lu B, Curiel DT, Zhu ZB.

    Mol Cancer Ther. 2004 Jun;3(6):687-91.PMID: 15210854 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control.

    Stoff-Khalili MA, Rivera AA, Nedeljkovic-Kurepa A, DeBenedetti A, Li XL, Odaka Y, Podduturi J, Sibley DA, Siegal GP, Stoff A, Young S, Zhu ZB, Curiel DT, Mathis JM.

    Breast Cancer Res Treat. 2008 Mar;108(1):43-55. Epub 2007 May 17.PMID: 17508279 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A new targeting approach for breast cancer gene therapy using the heparanase promoter.

    Breidenbach M, Rein DT, Schöndorf T, Khan KN, Herrmann I, Schmidt T, Reynolds PN, Vlodavsky I, Haviv YS, Curiel DT.

    Cancer Lett. 2006 Aug 18;240(1):114-22. Epub 2005 Nov 3.PMID: 16271435 [PubMed - indexed for MEDLINE]Related articles

    12.

    Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.

    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.

    Breast Cancer Res Treat. 2009 Sep;117(1):45-54. Epub 2008 Sep 13.PMID: 18791823 [PubMed - indexed for MEDLINE]Related articles

    13.

    Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.

    Zhu ZB, Makhija SK, Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA, Barker S, Yamaoto M, Li F, Alvarez RD, Curiel DT.

    Cancer Gene Ther. 2004 Apr;11(4):256-62.PMID: 15017380 [PubMed - indexed for MEDLINE]Related articles

    14.

    Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter.

    Li X, Zhang J, Gao H, Vieth E, Bae KH, Zhang YP, Lee SJ, Raikwar S, Gardner TA, Hutchins GD, VanderPutten D, Kao C, Jeng MH.

    Mol Cancer Ther. 2005 Dec;4(12):1850-9.PMID: 16373700 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.

    Rein DT, Breidenbach M, Kirby TO, Han T, Siegal GP, Bauerschmitz GJ, Wang M, Nettelbeck DM, Tsuruta Y, Yamamoto M, Dall P, Hemminki A, Curiel DT.

    Clin Cancer Res. 2005 Feb 1;11(3):1327-35.PMID: 15709205 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Viral mediated gene therapy for the management of metastatic thyroid carcinoma.

    DeGroot LJ, Zhang R.

    Curr Drug Targets Immune Endocr Metabol Disord. 2004 Sep;4(3):235-44. Review.PMID: 15379725 [PubMed - indexed for MEDLINE]Related articles

    17.

    A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.

    Yan C, Wen-Chao L, Hong-Yan Q, Rui Z, Wei-Lin J, Hua H.

    Acta Oncol. 2007;46(6):773-81.PMID: 17653900 [PubMed - indexed for MEDLINE]Related articles

    18.

    The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.

    Van Houdt WJ, Haviv YS, Lu B, Wang M, Rivera AA, Ulasov IV, Lamfers ML, Rein D, Lesniak MS, Siegal GP, Dirven CM, Curiel DT, Zhu ZB.

    J Neurosurg. 2006 Apr;104(4):583-92.PMID: 16619663 [PubMed - indexed for MEDLINE]Related articles

    19.

    Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.

    Chung I, Schwartz PE, Crystal RG, Pizzorno G, Leavitt J, Deisseroth AB.

    Cancer Gene Ther. 1999 Mar-Apr;6(2):99-106.PMID: 10195877 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cyclooxygenase-2 promoter for tumour-specific targeting of adenoviral vectors to melanoma.

    Nettelbeck DM, Rivera AA, Davydova J, Dieckmann D, Yamamoto M, Curiel DT.

    Melanoma Res. 2003 Jun;13(3):287-92.PMID: 12777984 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk